These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8914042)

  • 1. Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure.
    Supaporn T; Sandberg SM; Borgeson DD; Heublein DM; Luchner A; Wei CM; Dousa TP; Burnett JC
    Kidney Int; 1996 Nov; 50(5):1718-25. PubMed ID: 8914042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
    Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-operation between particulate and soluble guanylyl cyclase systems in the rat renal glomeruli.
    Stepinski J; Wendt U; Lewko B; Angielski S
    J Physiol Pharmacol; 2000 Sep; 51(3):497-511. PubMed ID: 11016869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
    Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
    J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
    Valentin JP; Ying WZ; Sechi LA; Ling KT; Qiu C; Couser WG; Humphreys MH
    J Am Soc Nephrol; 1996 Apr; 7(4):582-93. PubMed ID: 8724892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition prevents myocardial infarction-induced increase in renal cortical cGMP and cAMP phosphodiesterase activities.
    Clauss F; Charloux A; Piquard F; Doutreleau S; Talha S; Zoll J; Lugnier C; Geny B
    Fundam Clin Pharmacol; 2015 Aug; 29(4):352-61. PubMed ID: 25939307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
    Hamad AM; Range S; Holland E; Knox AJ
    Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure.
    Matsumoto T; Wada A; Tsutamoto T; Omura T; Yokohama H; Ohnishi M; Nakae I; Takahashi M; Kinoshita M
    Am J Physiol; 1999 Jun; 276(6):H1935-42. PubMed ID: 10362673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturation of A71915-dependent inhibition of atrial natriuretic peptide-stimulated cyclic GMP production in isolated rat glomeruli.
    Norling LL; von Geldern T; Chevalier RL
    Biol Neonate; 1994; 66(5):294-301. PubMed ID: 7873695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
    Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
    Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of cGMP after infusion of ANP or nitroprusside in the maturing rat.
    Chevalier RL; Fern RJ; Garmey M; el-Dahr SS; Gomez RA; De Vente J
    Am J Physiol; 1992 Mar; 262(3 Pt 2):F417-24. PubMed ID: 1313644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclic GMP phosphodiesterases augments renal responses to atrial natriuretic factor in congestive heart failure.
    Margulies KB; Burnett JC
    J Card Fail; 1994 Oct; 1(1):71-80. PubMed ID: 9420635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ; Zhou HL; Burman M; Huang LB
    Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral ureteral obstruction increases glomerular soluble guanylyl cyclase activity.
    McDowell KA; Chevalier RL; Thornhill BA; Norling LL
    J Am Soc Nephrol; 1995 Nov; 6(5):1498-503. PubMed ID: 8589329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ; Cieslinski LB
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
    Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC
    Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANF-mediated renal cGMP generation in congestive heart failure.
    Margulies KB; Heublein DM; Perrella MA; Burnett JC
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F562-8. PubMed ID: 1849364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal glomerular response to atrial natriuretic peptide in rats with aortocaval fistulas.
    Norling LL; Thornhill BA; Chevalier RL
    J Am Soc Nephrol; 1996 Jul; 7(7):1038-44. PubMed ID: 8829119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure.
    Goltsman I; Khoury EE; Aronson D; Nativ O; Feuerstein GZ; Winaver J; Abassi Z
    J Cell Mol Med; 2019 Jul; 23(7):4779-4794. PubMed ID: 31087547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.